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Abstract
Purpose To assess health-related quality of life
(HRQOL) of subjects at risk of type 2 diabetes undergoing
lifestyle intervention, and predictors for improved
HRQOL.
Methods The Finnish Diabetes Risk Score was used by
general practitioners to identify individuals at risk. Low-
intensity interventions with an 18-month follow-up were
employed. HRQOL was assessed using the SF-36 at
baseline and compared with results from a general Nor-
wegian population survey and further at 6 and 18 months.
Simple and multiple linear regression analyses were
applied to identify predictors of changes in HRQOL of
clinical importance.
Results Two hundred and thirteen participants (50 %
women; mean age: 46 years, mean body mass index: 37)
were included: 182 returned for 18-month follow-up, of
whom 172 completed the HRQOL questionnaire. HRQOL
was reduced with clinical significance compared with
general Norwegians. The mean changes in HRQOL from
the baseline to the follow-up were not of clinical impor-
tance. However, one out of three individuals achieved a
moderate or large clinical improvement in HRQOL. The
best determinant for improved HRQOL was obtained for a
composite, clinically significant lifestyle change, i.e. both a
weight reduction of at least 5 % and an improvement in
exercise capacity of at least 10 %, which was associated
with an improvement in five out of the eight SF-36
domains.
Conclusion Subjects at risk of type 2 diabetes report a
clinically important reduction in HRQOL compared with
general Norwegians. The best predictor of improved
HRQOL was a small weight loss combined with a small
improvement in aerobic capacity.
Keywords Quality of life  Type 2 diabetes mellitus 
Prevention  Lifestyle  Obesity
Introduction
Lifestyle modification in subjects at high risk of type 2
diabetes mellitus (DM) has been proven effective in reduc-
ing the incidence of type 2 DM [1–3]. Two systematic
reviews that assessed the effects of lifestyle changes on the
prevention of type 2 DM showed that no studies reported
data on health-related quality of life (HRQOL) [4, 5]. The
negative consequences of both type 2 DM and obesity on
HRQOL have been well documented [6–8]. Significant
HRQOL improvements have been observed after weight
loss in obese individuals undergoing a variety of treatments
[7, 9], although a systematic review of randomised trials
reported inconsistent results [10]. The relative importance of
weight loss versus improved fitness regarding the improve-
ment in HRQOL via lifestyle modification is unclear.
Among women, weight loss seems to be the main contrib-
utor to improved HRQOL, whereas increased fitness yielded
disappointing effects [11]. In the Diabetes Prevention Pro-
gram, all facets of the significant improvement in HRQOL
observed were correlated primarily with weight loss [12].
The aim of this study was to assess HRQOL in an
unselected group of subjects at risk of type 2 DM
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undergoing lifestyle treatment and to identify predictors of
clinically important HRQOL improvements. Low-intensity
interventions with high applicability in ordinary clinical
practice were chosen.
Methods
Subjects and study design
Individuals at high risk of type 2 DM were identified by
general practitioners (GPs) using the seven-item ‘‘Finnish
Diabetes Risk Score’’ (FINDRISC) [13]. FINDRISC is
based on traditional risk factors for diabetes, such as body
mass index (BMI), waist circumference, inactivity and age.
Copies of the FINDRISC questionnaire were sent by post
to approximately 90 GPs in the four municipalities located
nearest to the hospital. Individuals aged 18–64 years with a
FINDRISC score C9, which implies a moderate-to-high
risk of type 2 DM, were invited to participate in the study.
Study inclusion was performed from March 2004 to Sep-
tember 2005, with an 18-month follow-up period. After
signing written informed consent, participants were allo-
cated randomly to an ‘‘individual physician group’’ (IG) or
an ‘‘individual physician plus interdisciplinary group’’
(IIG). Individual physician interventions in both groups
were delivered at baseline and at 6, 12 and 18 months.
Subjects in the IIG participated in an additional 18 h
group-based, interdisciplinary programme administered
over 16 weeks. Since no statistically significant differences
between intervention groups were found regarding change
in lifestyle or change in HRQOL, the results are presented
as a cohort study for all participants combined [14]. Details
regarding recruitment methods, FINDRISC, exclusion cri-
teria, the intervention programme and categorisation of
aerobic capacity and diet have been thoroughly explained
previously [14]. The study was approved by the Regional
Committee for Medical Research Ethics of southern
Norway.
Assessments
Socio-demographic features, height without shoes, weight
in indoor clothes and the results of a modified Bruce pro-
tocol on a treadmill for subjects with low aerobic capacity
were recorded at baseline and again after 6 and 18 months,
yielding maximal oxygen uptake reported as mL/kg/min. A
weight reduction C5 % and an improvement in exercise
capacity of C10 % from the baseline to the follow-up were
used as criteria for a clinically significant lifestyle change
[14]. HRQOL was assessed at the baseline, 6 and
18 months using the Medical Outcomes Survey, Short
Form 36 (SF-36), version 1. This is a generic instrument
that has been extensively tested nationally and interna-
tionally and has satisfactory reliability and validity. The
SF-36 has proven to be applicable to both healthy subjects
and patients with medical conditions, thereby rendering it
possible to draw comparisons between patients and the
general population [15, 16]. Normative data from the
general Norwegian population (n = 4,444) were used for
comparison [17]. The answers to the 36 items are coded
into eight domains; four are interpreted as physical indi-
cators (general health perception (GH), physical function-
ing (PF), role limitation physical (RP) and bodily pain
(BP)) and four are interpreted as mental health indicators
(mental health (MH), social functioning (SF), vitality (VT)
and role limitation emotional (RE)). The eight domains are
transformed to a scale of 0 to 100, in which 100 is the best
possible and 0 the worst possible health state [15]. Nor-
wegian SF-36 norm data for the age-group were used to
aggregate the two summary scales from z-score transfor-
mations of the eight domains, a physical component sum-
mary (PCS) and a mental component summary (MCS)
[16]. These summary scales are standardised, to achieve a
mean score of 50 and a standard deviation of 10 in the
general population. Scores above 50 represent better
functioning compared with the general population and vice
versa.
Definition of end-points
One of the challenges of studying HRQOL is that
improvements that are statistically significant can, never-
theless, be of little clinical relevance [18]. The primary
outcomes of this paper were clinically important changes in
HRQOL. On a 100-point scale, mean score changes of
5–10 points were interpreted as small, changes of 10–20
points were considered moderate and changes of [20
points were considered large clinical changes [19, 20].
Regarding the summary scales (PCS and MCS), a 2–5
point change was interpreted as small, a 5–8 point change
was considered moderate and a C8 point change was
considered large, corresponding to effect sizes of
0.20–0.49, 0.50–0.79 and C0.80 [16, 20]. Changes (D
values) in the eight domains and two summary scores were
calculated by subtracting the baseline value from the fol-
low-up value, i.e. a positive value implies an improvement,
whereas a negative value implies a worsening of HRQOL.
Statistical analyses
Statistical analyses were carried out using the Statistical
Package for Social Sciences (SPSS), version 18.0. Differ-
ences in means between groups were assessed using an
independent samples t test for continuous variables with
normal distribution, and the v2 test was used for categorical
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variables. Mean differences between the study group and
normative data were assessed using the t test. Paired
sample t test was used to detect changes in HRQOL data
over time.
Simple linear regression analyses and multiple linear
regression analyses (GLM procedure in SPSS) were
applied to identify significant predictors of changes in
HRQOL from baseline to follow-up for the eight domains
and the two summary scales, with adjustment for baseline
HRQOL values in the multiple analyses. Independent
variables in the multiple regression analyses were
selected based on both clinical experience and findings
from a previous study that showed that socio-demo-
graphic variables (age, sex, living conditions and edu-
cation) influence HRQOL [21]. Further, regarding the
uncertainty about the relative importance of weight loss
versus improved fitness regarding the improvement in
HRQOL, the weight goal alone, the aerobic capacity goal
alone and the two combined were tested in the multiple
linear regression analyses. To strengthen the analyses for
the combined lifestyle achievement, multiple logistic
regression analyses were also performed using the same
independent variables; these yielded the odds ratios
(ORs) for at least a small, clinically significant change in
HRQOL as the dependent variable. Confidence intervals
(CIs) were reported at the 95 % level. The level of sig-
nificance was set at p B 0.05.
Results
Sixty-five of the *90 GPs who received the FINDRISC
questionnaires referred at least one subject from March
2004 to September 2005. Out of the 234 eligible subjects at
risk, all 213 individuals who wanted to participate were
included in the study (Fig. 1). Of the 213 randomised
subjects, 212 completed the SF-36 questionnaire at base-
line and 172 (81 % of the randomised individuals) of the
182 subjects who attended the follow-up assessment
completed the final SF-36 questionnaire. Unhealthy life-
style parameters were prevalent: The mean BMI was 37,
90 % of subjects had a BMI [30, three out of five had an
unhealthy diet, more than 50 % had poor aerobic capacity,
and every fourth participant smoked daily (Table 1).
Compared with the general Norwegian population, the
population at risk of type 2 DM reported at baseline both
statistically significant and clinically important deficits in
HRQOL for all eight domains of the SF-36 and for the
summary scores (Table 2), with the greatest disparities
observed for the physical domains. The 15 % of subjects
who dropped out reported clinically important deficits in
HRQOL scores at baseline than did the completers of the
study (Table 2).
The mean weight loss and mean increase in maximal
aerobic capacity from the baseline to the follow-up were
2 % (SD, 6) and 12 % (SD, 25), respectively. Corre-
spondingly, the mean changes in all HRQOL scores were
Fig. 1 Flow diagram of participant selection throughout the trial
Table 1 Baseline characteristics. Values are means with standard
deviation (SD) or percentage
All
n = 213
Socio-demographic data
Age 46.5 (11)
Gender, men (%) 50
Married or cohabiting, % 74
High school/university, % 28
Employed, % 62
Long-term sick leave/disabled, % 32
Daily smoker, % 25
Weight measures
Weight, kg 112.2 (22)
Body mass index, kg/m2 36.8 (6.0)
Waist circumference, cm 119 (14)
Diet
Healthy diet, % 1
Somewhat unhealthy diet, % 39
Unhealthy diet, % 60
Aerobic capacity, ml/kg/min (n = 201) 26.8 (7.6)
Good, excellent or superior aerobic capacity, % 25
Poor or very poor aerobic capacity, % 55
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small and not of clinical importance (Table 3, 4). However,
a moderate or large clinical improvement in HRQOL was
achieved in about one out of three participants, with the
highest proportions found for general health (42 %) and
vitality (41 %), the lowest for emotional role limitation
(18 %) and the two summary scales in the middle with PCS
(32 %) and MCS (31 %). The improvements in HRQOL
were basically achieved during the first 6 months and
thereafter stabilised (Table 4).
A simple linear regression analysis uncovered that
improved PCS was correlated with weight loss and
improved fitness, respectively, i.e. 1.5 points for every 5 kg
lost and 3.4 points for every 5 mL/kg/min improvement in
maximal aerobic capacity. No significant correlations were
identified for improved MCS.
In a multiple linear regression analysis, using HRQOL
score as the dependent variable revealed that a weight
reduction C5 % alone was associated with improvement in
one physical domain (GH with B = 7.6 (2.4–12.9)), one
mental domain (VT with B = 8.4 (2.3–14.5)) and one
summary scale (PCS with B = 2.9 (0.2–5.6). In the same
model, an improvement in exercise capacity C10 % alone
was correlated with improvement in only one physical
domain (BP with B = 8.9 (0.8–17.1)) and one summary
scale (PCS with B = 3.5 (0.6–6.5). Further, this model
demonstrated that the best predictor of improved HRQOL
was a clinically significant lifestyle change defined as both
a weight reduction C5 % and an improvement in exercise
capacity C10 % from the baseline to the follow-up
(Table 5). This combined lifestyle change was associated
with improvement in three of four physical domains (not
RP), two out of four mental components (VT and SF) and
one of the two summary scales (PCS) of the SF-36 ques-
tionnaire (Table 5). The achievement of this composite
lifestyle change was correlated with a large effect on PCS
score compared with individuals who did not achieve it,
with an unadjusted improvement on PCS of 7.8 (3.4–10.7)
and an adjusted improvement of 6.4 (2.9–9.8) (Fig. 2;
Table 5).
Table 2 Baseline values for HRQOL (SF-36) in the study population, from the general Norwegian population and from completers versus
dropouts of the study
SF-36 domain* All Norm # Completers Dropouts
n = 212 n = 4,444 n = 182 n = 30
Bodily pain (BP) 60 (29) 75 (25)*** 62 (28) 46 (31)**
General health (GH) 58 (24) 77 (21)*** 60 (24) 42 (22)***
Physical function (PF) 75 (20) 90 (17)*** 77 (19) 63 (21)***
Physical role limitation (RP) 64 (41) 82 (34)*** 66 (40) 49 (42)*
Mental health (MH) 74 (18) 80 (15)*** 76 (17) 64 (23)**
Social function (SF) 79 (26) 87 (20)*** 81 (24) 65 (31)**
Vitality (VT) 47 (23) 61 (20)*** 49 (22) 37 (23)**
Emotional role limitation (RE) 76 (37) 87 (29)*** 79 (36) 55 (41)**
Physical component summary (PCS) 41 (12) 50 (10)*** 42 (12) 36 (11)*
Mental component summary (MCS) 47 (13) 50 (10)*** 48 (12) 41 (15)*
Data are presented as means (SD). Norm # normative data from the general Norwegian population aged 18–64 years. Independent samples t test
between the whole study population (All) and Norm # and Completers and dropouts
* p \ 0.05, ** p \ 0.01 and *** p \ 0.001)
Table 3 D values from the baseline to the follow-up for HRQOL
(SF-36) shown for all subjects and for those achieving and not
achieving two main lifestyle change goals (weight reduction C5 %
and improved aerobic capacity C10 %)
SF-36 domain* All Not
achieving
both goals
Achieving
both
goals
n = 172 n = 96 n = 26
Bodily pain (BP) 0 (25) -2 (22) 13 (29)*
General health (GH) 4 (18) 2 (17) 14 (16)**
Physical function (PF) 5 (16) 5 (13) 17 (15)***
Physical role limitation (RP) 0 (40) 1 (37) 15 (42)
Mental health (MH) 2 (18) 2 (16) 7 (16)
Social function (SF) 3 (25) 0 (21) 14 (24)**
Vitality (VT) 5 (22) 3 (22) 17 (16)**
Emotional role limitation
(RE)
3 (39) 6 (30) 3 (38)
Physical component
summary (PCS)
2 (9) 1 (8) 8 (9)***
Mental component
summary (MCS)
1 (13) 1 (11) 4 (11)
Data are presented as means with standard deviations in parenthesis.
p values based on an independent samples t test performed between
those achieving and not achieving the lifestyle change (* p \ 0.05,
** p \ 0.01 and *** p \ 0.001)
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Based on a multiple logistic regression model, the
adjusted ORs for small clinically significant improvements
in HRQOL for achievers of the composite lifestyle change
versus non-achievers were statistically significant for three
physical domains (GH, PF and BP), but none of the mental
domains or the summary scales. The OR was highest for
GH (7.0 (2.2–21.8)) and quite similar for PF (3.9
(1.2–13.3)) and BP (4.0 (1.4–12.1)).
Discussion
This study showed that subjects at risk of type 2 DM had
markedly lower HRQOL than did the general Norwegian
population on all eight domains of the SF-36 and on the
PCS and MCS summary scales. However, HRQOL
improvement in clinical importance was accomplished by a
moderate lifestyle change achieved with modest clinical
efforts.
The limitations of the study must be considered
First, dropouts differed from completers of the study,
reporting significant decrements in HRQOL at the baseline.
Thus, individuals who were most dissatisfied with their
lives and who were in most need of a lifestyle change
unfortunately seemed to dropout of the study. This obser-
vation coincided with results from a large meta-analysis
and the experiences of many health care providers: ‘‘Those
who need it the most, understand it the least’’, which rep-
resents a major healthcare challenge [22].
Second, HRQOL was assessed using a generic instru-
ment, not a disease-specific one. An obesity-specific
instrument may have better sensitivity to detect changes
than a generic one. The generic SF-36 was chosen since we
only included subjects at risk of a disease. A mean BMI of
37 was a surprising finding in this study. Conversely, one
of the major advantages of a generic questionnaire is the
possibility to draw comparisons between the study group
and the general population and between a variety of med-
ical conditions [6].
Third, the results of this study may be biased by a
clustering bias of GPs referring the patients to the study or
a selection bias through the participants’ willingness to
participate. However, we are not, the way the study was
designed, able to correct for these biases. Further, the
attendance rate at the final fitness test weakens the study
results assessing predictors, also due to a possibility of
selection bias, i.e. those who achieve lifestyle changes turn
up for the final assessment to a larger extent than those who
do not.
Fourth, regarding the applicability of the results, the
effects may have been overestimated because of a healthy
volunteer bias: Volunteers are fitter and healthier than non-
volunteers [23, 24]. On the other hand, as shown in
Table 5, baseline values for all ten variables from the SF-
36 questionnaire are inversely correlated with improve-
ments in the same variables, i.e. HRQOL seems easier to
improve if baseline values are low compared to high,
thereby supporting the general tendency of the ‘‘regression
to the mean’’ bias. This may support a tendency towards
underestimation of the effects if those with even lower
HRQOL had participated in the study. However, we are not
able to exploit these potential biases thoroughly.
Finally, a follow-up time of 18 months does not auto-
matically imply that the effects achieved are sustainable. It
is common knowledge in lifestyle interventions weight loss
studies that results diminish overtime [22]. We have no
further follow-up assessment data.
The strengths of this study were as follows: First, the
simple selection of eligible patients by GPs using the
FINDRISC questionnaire. Second, an inclusion rate
[91 %, a participation rate [98 %, the absence of exclu-
ded subjects and a dropout rate B15 % are all robust
Table 4 Mean HRQOL values
(SF-36) from baseline and
6 months to 6 and 18-month
follow-up, respectively
Paired sample t test. Data are
presented as means with
standard deviations in
parentheses. Values marked
with bold indicate statistical
significance (* p \ 0.05,
** p \ 0.01 and
*** p \ 0.001)
SF-36 domain* Baseline 6 months 6 months 18 months Baseline 18 months
n = 166 n = 166 n = 150 n = 150 n = 172 n = 172
Bodily pain (BP) 62 (27) 62 (27) 63 (27) 62 (29) 62 (28) 62 (30)
General health (GH) 60 (23) 64 (23)* 64 (23) 64 (23) 59 (24) 64 (23)**
Physical function (PF) 78 (18) 80 (18)** 81 (17) 82 (17) 76 (19) 81 (18)***
Physical role limitation (RP) 65 (40) 71 (38)* 73 (37) 65 (40)** 65 (40) 65 (41)
Mental health (MH) 76 (17) 77 (17) 78 (16) 77 (18) 76 (17) 78 (17)
Social function (SF) 81 (25) 84 (23) 84 (22) 83 (23) 80 (25) 83 (23)
Vitality (VT) 49 (21) 53 (22)* 53 (22) 52 (24) 48 (22) 53 (23)**
Emotional role limitation (RE) 79 (36) 84 (31) 85 (30) 81 (35) 79 (36) 81 (34)
Physical component summary
(PCS)
42 (11) 44 (11)* 44 (11) 44 (11) 42 (12) 44 (12)*
Mental component summary
(MCS)
48 (13) 50 (12) 50 (12) 49 (14) 48 (13) 50 (13)
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characteristics for this clinical study [14]. The general
applicability of these results to common clinical settings
should thus be good.
As 90 % of the study population was obese, and obesity
is related to a lower HRQOL [6], the finding of reduced
HRQOL in this study was as expected; however, the
magnitude of the difference compared with the general
Norwegian population was surprising. Two large meta-
analyses have shown that, among obese persons, those not
seeking treatment have the best HRQOL, those seeking
conservative treatment have a more moderate HRQOL and
those seeking surgery have the worst HRQOL [25, 26]. It is
surprising that the subjects in this study, who were not
seeking treatment for obesity, but were assessed to be at
risk of type 2 DM through a questionnaire survey, reported
an HRQOL that was as low as that of subjects undergoing
bariatric surgery [26]. Decreased HRQOL in subjects at
risk of type 2 DM is not a new finding [27, 28]. However,
in contrast to findings from Finland, where subjects at risk
reported lower general health and increased bodily pain
compared with the general Finnish population, all eight
dimensions of the SF-36 were significantly lower in our
study [28]. This can be explained by the much higher
prevalence of obesity in the present study (90 %) compared
with the study from Finland (31 %). Chittleborough et al.
studied HRQOL along the diabetes continuum in Australia
and found a significantly lower score for bodily pain
exclusively (i.e. increased pain) among those with impaired
fasting glucose compared with those with normal glucose
levels, whereas those with diabetes scored significantly
lower on all dimensions, with the exception of mental
health [27].
The relative importance of weight loss versus improved
fitness regarding the improvement in HRQOL in this study
showed an improvement of 1.5 PCS points for every 5 kg
lost and 3.4 points for every 5 mL of improvement in
maximal aerobic capacity (mL of O2 uptake/kg/min). No
correlations between changes in body weight or fitness and
MCS were found. Correspondingly, improvements in only
two of the eight and one of the eight domains of the SF-36
were associated with weight loss or fitness improvement
alone, respectively. However, the combination of both
weight reduction and improved fitness was most highly
correlated with improved HRQOL. Five out of the eight
domains of the SF-36 were significantly improved in sub-
jects who made a clinically significant lifestyle change
(Table 5). Nevertheless, the correlation observed for DPCS
was very weak, with an adjusted R2 of 0.287, which means
that only 28.7 % of the variation observed can be explained
by this lifestyle change. In other words, most of the vari-
ation in DPCS could not be explained by the variables
identified in this study. However, the study showed that
subjects who attained clinically significant lifestyle chan-
ges exhibited an improved HRQOL. The greatest impact
was found for physical HRQOL domains of functioning,
which was in accordance with the results of other studies
[6]. Subjects who exhibited an improvement in both weight
and fitness may experience a new way of living when
approximating their motivational goals. Our experience is
that those who achieve both weight reduction and
improved fitness often become very dedicated to their
changes in lifestyle, in a way that is very similar to that
adopted by those who want to quit smoking or alcohol
abuse. Achieving their goals after such large motivational
changes can then lead to a considerable improvement in
reported HRQOL.
A large meta-analysis has shown that an obesity-
specific HRQOL instrument reflected weight-related
QOL with much better sensitivity than did the SF-36,
and found that factors other than weight change were
crucial for HRQOL changes [26]. The finding of a much
lower HRQOL in the subjects included in this study
compared with the general population based on the
generic instrument SF-36 may be due to more emotional
and complex problems in life, for which weight loss is
not the ‘‘simple’’ solution. Obesity is a major public
health problem, as a risk factor for a variety of illnesses
and as having a devastating impact on HRQOL. This
study confirmed the negative consequences of obesity
on HRQOL. It also confirmed that even small changes
in lifestyle may enhance HRQOL significantly, and that
most subjects at risk of type 2 DM are obese, which are
all in accordance with the findings of other reviews [6,
7]. Many health care professionals argue that, regarding
obesity, for which a cure is unlikely, one of the most
important health outcomes that warrants evaluation and
improvement is quality of life [7]. We believe that
lifestyle changes at a moderate level, as exemplified by
a modest increase in physical activity and a small
weight loss, will be the most important elements in
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Fig. 2 Changes in PCS and MCS scores associated with achieving or
not achieving the combined lifestyle change (weight reduction C5 %
and improvement in exercise capacity C10 % from the baseline to the
follow-up) based on independent t tests
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improving HRQOL for subjects at risk of type 2 DM.
Improvement in HRQOL should, perhaps, be the main
goal at the start of treatment, as this may increase the
chances for further therapeutic success. In the future,
preventive programmes including weight control and
exercise should be established for the large proportion
of subjects at risk of type 2 diabetes. An individual
approach, such as that shown in this study, can be used
with modest clinical efforts while yielding clinically
important results.
Conclusions
In summary, this study of subjects at risk of type 2 DM
showed that HRQOL was markedly reduced in this popu-
lation. A clinically important improvement in HRQOL was
clearly correlated with the achievement of a composite
lifestyle change (weight reduction and improved aerobic
capacity). However, correlation is not causation. But this
association may indicate that important HRQOL
improvements can be achieved by small improvements in
lifestyle changes in subjects at risk of type 2 diabetes.
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